General Session Location: Komatke A/B/C/D | |
12:00 PM | Welcome |
12:15 PM | Health Disparities in Tribal Communities |
12:45PM | The Evolving Role of OPOs in a Changing Environment |
Future of OPO in the Era of CMS Metrics | |
Centralized DCD to Maximize Organ Donation & Allocation | |
Q&A Discussion |
1:55PM | What Can the American Board Surgery Offer Transplant Surgeons |
ABS Intro & Explanation | |
Panel Discussion |
2:35PM | Oral Abstract Session I |
Programmatic Normothermic Machine Perfusion Improves Liver Transplant Waitlist Outcomes for Patients with Lower MELD Scores: A Multi-Center Study | |
Alpha-Gal-KO Xenothymokidney Function in a Living Human Recipient with a Durable Mechanical Circulatory Support Device | |
Public Perceptions of Organ Donation by Determination of Death & Procurement Technique | |
Out of Sequence Liver Transplants: A Nationwide Analysis of Organ Utilization & Allocation Equity |
3:15PM | Break |
3:35PM | Najarian Lecture |
4:20PM | Novel Approaches in Transplant |
Everything Robotic: Robotic Donor Hepatectomy & Robotic Liver Transplant: World Largest Experience | |
Clinical Renal Xenotransplantation - The First Living Recipient & Current Challenges | |
Flip the Liver: Reduced Left Lateral & Monosegment Liver Transplants in Pediatric Recipients with Long Term Outcomes | |
Applications of AI in Transplantation | |
Optimizing Transplant Outcomes from Older Donors | |
Q&A Discussion |
5:30PM | Poster Session A |
7:00AM | Breakfast |
8:00AM | Advanced Transplant Provider Session |
APP Committee Updates & Welcome! | |
We Are Burned Out, Now What? | |
Assessing the Impact of Health Literacy Interventions on Post-Transplant Outcomes | |
Transplant Oncology: Current Indications & Future Directions | |
Simultaneous Heart Kidney Transplant vs Safety Net Kidney after Heart Transplant | |
Normothermic Regional Perfusion: The Who’s, What’s, Where’s, When’s, Why’s & How’s | |
APPs in Liver Transplant: Perception, Implementation & Effect | |
Delayed Not Denied Graft Function – Strategies to Optimize Outcomes | |
Increasing Access to Living Kidney Donation through Standardization & Removing Barriers | |
About Face: Current Issues & Clinical Advances in VCA Facial Transplantation |
8:00AM | Session A: So You Want to Be a Mentor? |
Becoming a Mentor & Staying a Mentor through the Years | |
Introduction to Cross Mentorship - Mentoring at All Levels | |
How to Engage with Mentees. Where Do You Start? | |
How the ATP Committee Has Grown Mentorship in ASTS | |
Q&A Discussion |
8:00AM | Session B: Pancreas Transplantation: Improving Our Workforce, Training, and Mentorship |
Pancreas Procurement & Backbench | |
Training Future Pancreas Transplant Surgeons | |
Post-Operative Management of Pancreas Transplant Recipients | |
Islet Transplantation: Current Updates & FDA Approval in the United States | |
Q&A Discussion |
9:10AM | Session A: LDLT Training and Certification – Is It Time To Move Forward? |
How Did We Do It? | |
Utilizing Innovative Techniques? Can We Go Virtual? | |
Who is Responsible for Certification Oversight & Quality Metrics? | |
Q&A Discussion |
9:10AM | Session B: No Kidneys Left Behind |
HBV & HCV to Naive | |
Peds En Bloc/Dual Kidneys | |
How to Handle High KDPI/Bad Biopsies or Pump Numbers | |
Q&A Discussion |
10:20AM | Transplant Oncology |
Liver Transplantation for Colorectal Liver Metastasis in the US & World | |
Role of Liver & Multivisceral Transplants for Treatment of Metastatic Neuroendocrine Tumors | |
Current Protocols in Liver Transplantation for Intrahepatic & Hilar CCA | |
Current Perspectives in Transplantation for Liver Malignancies | |
Q&A Discussion |
11:30AM | Lunch Symposium Sponsored by: CareDx |
11:30AM | Lunch Symposium Sponsored by: Paragonix |
11:30AM | Exhibit Hall Open |
General Session Location: Komatke A/B/C/D | |
12:30PM | Creating Future Surgeon Scientists |
Support from the Chair: Creating Future Surgeon-Scientists | |
How to Manage a Busy Practice & Successful Research Laboratory? | |
Maximizing Collaboration Between Surgeons & Scientists and Societies | |
How the ASTS Surgeon-Scientist Committee Can Propel Your Career | |
Q&A Discussion |
1:35PM | Research Grants Session |
2022 ASTS-Veloxis Fellowship in Transplantation Grant Update | |
2022 ASTS Collaborative Scientist Grant Update | |
2021 ASTS-Natera Socio Economic and Racial Disparity Grant SERD Update | |
Q&A Discussion |
2:25PM | Award Ceremony I |
2:50PM | Hume Lecture |
3:25PM | Break |
3:45PM | Oral Abstract Session II |
Prolonged Time from Cross Clamp until Normothermic Machine Perfusion Start is Associated with Increased Risk of Early Allograft Dysfunction Following DCD Liver Transplant | |
U.S. Organ Procurement Organization Donor Care Unit Model Comparisons | |
Rising Trends of Alcohol-Induced Liver Disease-Associated Hospitalizations and Liver Transplants in the United States | |
Expedited Lung Allocation in the Era of Continuous Distribution |
4:30PM | Congress, the OPTN & ASTS: What to Expect from Capitol Hill in 2025 |
The Transplant Advocacy Landscape in a Post-Election Era | |
Post Election Congress: Leaders & Legislative Items to Watch | |
OPTN & Capitol Hill: What to Expect in the Year Ahead | |
Q&A Discussion |
5:45PM | Poster Session B |
7:15PM | Outdoor Games Night! |
7:00AM | Breakfast |
8:00AM | The Practical Implementation of NRP in Your Program |
Technical Considerations | |
The Finances of NRP? What is the Cost & Benefit? | |
Should You Use In-House or Hire a Team? | |
Established Parameters for Use? | |
Q&A Discussion |
9:20AM | Biomarkers During Ex Situ Machine Perfusion |
Introduction & Overview | |
Standardizing Viability Assessment in Normothermic Machine Perfusion | |
Is There Utility of Biomarkers in Hypothermic Machine Perfusion | |
Q&A Discussion |
10:25AM | Robotic Surgery in Transplantation |
Starting a Robotic Living Donor Hepatectomy Program: Considerations & Pitfalls | |
Starting a Robotic Kidney Transplant | |
Starting a Robotic Pancreas Transplant | |
Q&A Discussion |
11:30AM | Lunch Symposium Sponsored by: TransMedics |
11:30AM | Exhibit Hall Open Location: Akimel Ballroom |
12:35PM | Oral Abstract Session III |
Living Donor Liver Transplantation for Young Biliary Atresia Recipients is Associated with Improved Outcomes in the Modern Era | |
Uncovering the Mechanisms of Delayed Graft Function (DGF) in Human Kidney Transplants Using Single-Cell Spatial Transcriptomics |
1:20PM | Awards Ceremony II |
1:45PM | President's Address |
3:30PM | ATP/Ronald McDonald House Event |
5:30PM | Pints with Professors for Resident & Medical Students |
6:30PM | Reception & Dinner |
7:00AM | Breakfast |
General Session Location Kave 1/2/3 | |
8:00AM | Mini Oral Abstracts |
Outcomes By Epstein-Barr Virus Serostatus In Pediatric Kidney Transplantation | |
Early Post-Transplant Clinical Outcomes from the Largest Real-World Multi-Center Study of Controlled Moderate Hypothermic Preservation of Donor Livers | |
Death Following Living Liver Donation: The National Experience Over Three Decades | |
Transforming The Logistics of Liver Transplantation With Normothermic Machine Perfusion: Clinical Impact Versus Cost | |
Rescuing Hard to Place Kidneys Using a Centralized Normothermic Machine Preservation and Assessment Service | |
Preventing Connexin 43 Gap Junction Loss in Donor Graft Endothelium Enhances Allograft Protection | |
Preservation of Discarded Human Kidneys for 10 days at Subzero Temperature |
8:45AM | Value Based Care in Transplantation |
Roadmap to the Future - Introduction | |
Regulatory Changes Impacting Transplant Patients | |
Effect on Education & Clinical Care | |
Q&A Discussion |
10:00 AM | Measuring Progress & Success Towards OPTN Modernization Moderated by: Ginny Bumgardner, MD, PhD Panelists: AAKP – Ed Hickey AOPO – Jennifer Prinz ASHI – Cathi Murphey AST - TBA NATCO – Donna Dick The Alliance – John Magee |
11:30 AM - Program End - Thank you for attending!